Evidence map›Paper›PMID 31417278›Full record

ArticleOncoTargets and therapy2019

Ting-Juan Zhang, Xiang-Mei Wen, Jing-Dong Zhou, Yu Gu, Zi-Jun Xu, Hong Guo, Ji-Chun Ma, Qian Yuan, Qin Chen, Jiang Lin and 1 more

Open access · goldAbstract read
In one paragraph

Article in OncoTargets and therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Clinical applications of abnormal DNA methylation in chronic myeloid leukemia.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2024
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Ting-Juan Zhang *Department of Hematology, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China.
Xiang-Mei Wen *Zhenjiang Clinical Research Center of Hematology , Zhenjiang, Jiangsu, People's Republic of China.
Jing-Dong Zhou *Department of Hematology, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China.
Yu GuDepartment of Hematology, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China.
Zi-Jun XuZhenjiang Clinical Research Center of Hematology , Zhenjiang, Jiangsu, People's Republic of China.
Hong GuoZhenjiang Clinical Research Center of Hematology , Zhenjiang, Jiangsu, People's Republic of China.
Ji-Chun MaZhenjiang Clinical Research Center of Hematology , Zhenjiang, Jiangsu, People's Republic of China.
Qian YuanDepartment of Hematology, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China.
Qin ChenZhenjiang Clinical Research Center of Hematology , Zhenjiang, Jiangsu, People's Republic of China.
Jiang LinZhenjiang Clinical Research Center of Hematology , Zhenjiang, Jiangsu, People's Republic of China.
Jun QianDepartment of Hematology, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China.
Jiangsu University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOur previous study has reported that aberrant

methods

results

conclusionOur study revealed that

Indexed as

chronic myeloid leukemiamethylationprogressionSOX30

Identifiers

PMID31417278
PMCPMC6592060
OpenAlexW2952123283

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.